The Effectiveness of a Chatbot-facilitated High Alert Medication Education for 2-year Post Graduate Nurses

September 6, 2023 updated by: Shin Kong Wu Ho-Su Memorial Hospital
This study involves three stages. In the first stage, qualitative research design is used to understand clinical nurses' learning needs on high alert medication. In the second stage, " high alert medication knowledge inventory " and " high alert medication safety inventory " will be developed based on the literature and results from qualitative study in the stage one. In the third stage, randomized control trail study design will be used. The nursing staffs in the experimental group receive " online simulation of high alert medication safety training ", the staffs from the control group receive classroom teaching regarding high alert medication". A total of 124 nurses will be invited to participate in this study, 62 subjects will be assigned in each group . After the intervention, we will examine the learning effectiveness.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
      • Taipei City, Taiwan, 111
        • Recruiting
        • He Ting-I
        • Contact:
          • Ting-I He
          • Phone Number: 0976335848

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Nursing staff who are licensed and have passed the Medication Safety Course for Newcomers to independently perform drug delivery techniques.
  2. Nursing staff who are willing to participate in this research and complete the research consent form.

Exclusion Criteria:

  1. Not fully involved in the study
  2. Nursing staff not involved in dispensing medicine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: online simulation of high alert medication safety training
Other: online simulation of high alert medication safety training
online simulation of high alert medication safety training
No Intervention: classroom teaching regarding high alert medication

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
high alert medication knowledge inventory
Time Frame: Change from Baseline high alert medication knowledge inventory at 1 months
Nurse ' medication knowledge
Change from Baseline high alert medication knowledge inventory at 1 months
high alert medication safety inventory
Time Frame: Change from high alert medication safety inventory at 1 months
Nurse ' medication safety
Change from high alert medication safety inventory at 1 months
Learning Engagement Scale
Time Frame: Change from high alert medication safety inventory at 1 months
Nurse ' Learning Engagement Scale
Change from high alert medication safety inventory at 1 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Learning satisfaction
Time Frame: through study completion, an average of 1 Week
Learning satisfaction
through study completion, an average of 1 Week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shin Kong Wu Ho-Su Memorial Hospital

Collaborators

National Taipei University of Nursing and Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

May 23, 2023

First Submitted That Met QC Criteria

August 2, 2023

First Posted (Actual)

August 9, 2023

Study Record Updates

Last Update Posted (Actual)

September 11, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 20221007R

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

There is a plan to make IPD and related data dictionaries available.

IPD Sharing Time Frame

starting in January 2025 until January 2030

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe